Your guide to trends and revenue prospects for vaccine production
What’s the outlook for producing vaccines? Visiongain’s updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies.
Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your research and analyses.
There’s rising demand for those products and services. In particular, outsourced vaccine manufacturing will expand from 2013 to 2023, with growing revenues.
Forecasts and other analyses to help you stay ahead in knowledge
In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. Also, you see qualitative analysis (SWOT and STEP), business news, outlooks and developmental trends. You receive 70 tables, 46 charts and two research interviews.
You discover industry dynamics and growth potentials – the following sections show what you find in our new report.
Discover prospects for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2023 for these five submarkets:
• Paediatric vaccines
• Influenza vaccines
• Adult prophylactic vaccines
• Therapeutic vaccines
• Contract vaccine manufacturing.
You gain advantages by understanding trends, opportunities and challenges. Our investigation shows what will stimulate and restrain business.
Our work also breaks the main world forecast into leading geographical markets.
What prospects for leading regions and countries?
Developments worldwide will influence the market from 2013, especially production of vaccines in emerging countries. There exist many opportunities for pharma companies and contract manufacturing organisations (CMOs). See prospects for the industry.
You get individual forecasts to 2023 for eleven national markets, finding overall revenues:
• Germany, France, UK, Italy and Spain (EU5)
• Brazil, Russia, India and China (BRIC nations).
Discover progress and outlooks. You assess the industry’s future – hear about developments and find their significance. Our work explains, exploring many issues.
What affects vaccine manufacturing from 2013?
Our report discusses issues and events affecting that industry and market from 2013 onwards:
• Cell-based techniques – mammalian cell lines, avian-derived cells, plant-based processes and other methods
• Next-generation expression systems and vectors – increasing yields
• Recombinant DNA technologies
• Equipment, including single-use (disposable) bioreactors and prefilled syringes
• Product stability, lyophilisation and quality assurance programmes.